Skip to main content

General Principles of Validating a Molecular Test

  • Chapter
Molecular Oncology Testing for Solid Tumors
  • 1237 Accesses

Abstract

Before a molecular test is implemented for reporting patient results, it is the responsibility of the laboratory to validate or verify, as well as to document, the performance characteristics of the assay. Such performance characteristics relate to the accuracy, precision, and robustness of the test in measuring the analyte for the intended purposes of the test. Assay validation is an extensive process that has to conform to the standards, as determined by regulations such as the ones passed by the US Congress in 1988: the Clinical Laboratory Improvement Amendments (CLIA-’88). The standards implemented by CLIA-’88 were designed to ensure the accuracy and reliability of human patient testing results regardless of where the test was performed. CLIA-’88 regulations established different complexity levels of laboratory tests. As such, laboratory testing is divided into simple or “waived” tests, tests of moderate complexity, and high complexity tests. All molecular tests fall within the “high-complexity” category as defined by CLIA-’88 [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Medicare. Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)-HCFA. Final rule with comment period. Fed Regist. 1992;57:7002–186.

    Google Scholar 

  2. Ferreira-Gonzalez A, Emmadi R, Day SP, et al. Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology. J Mol Diagn. 2014;16:3–6.

    Article  PubMed  Google Scholar 

  3. Clinical and Laboratory Standards Institute. Establishing molecular testing in clinical laboratory environments: approved guideline. CLSI document MM19-A. Wayne, PA: CLSI; 2011.

    Google Scholar 

  4. Clinical and Laboratory Standards Institute. Molecular diagnostic methods for genetic diseases: approved guideline. CLSI document MM1-A2. 2nd ed. Wayne, PA: CLSI; 2006.

    Google Scholar 

  5. Clinical and Laboratory Standards Institute. Nucleic acid sequencing methods in diagnostic laboratory medicine: approved guideline. CLSI document MM09-A2. 2nd ed. Wayne, PA: CLSI; 2014.

    Google Scholar 

  6. Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative analytical methods: approved guideline. CLSI document EP6-A. Wayne, PA: CLSI; 2003.

    Google Scholar 

  7. Clinical and Laboratory Standards Institute. Verification and validation of multiplex nucleic-acid assays: approved guideline. Document MM17-A. Wayne, PA: CLSI; 2008.

    Google Scholar 

  8. Jennings L, Van Deerlin VM, Gulley ML. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med. 2009;133:743–55.

    PubMed  Google Scholar 

  9. Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010;23:550–76.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol. 2000;53:666–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Dumur CI, Sana S, Ladd AC, et al. Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples. Diagn Mol Pathol. 2008;17:200–6.

    Article  CAS  PubMed  Google Scholar 

  12. Baloglu G, Haholu A, Kucukodaci Z, et al. The effects of tissue fixation alternatives on DNA content: a study on normal colon tissue. Appl Immunohistochem Mol Morphol. 2008;16:485–92.

    Article  CAS  PubMed  Google Scholar 

  13. Clinical and Laboratory Standards Institute. Evaluation of matrix effects: approved guideline. CLSI document EP14-A2. 2nd ed. Wayne, PA: CLSI; 2005.

    Google Scholar 

  14. Clinical and Laboratory Standards Institute. User verification of performance for precision and trueness: approved guideline. CLSI document EP15-A3. 3rd ed. Wayne, PA: CLSI; 2014.

    Google Scholar 

  15. Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures: approved guideline. CLSI document EP5-A3. 3rd ed. Wayne, PA: CLSI; 2014.

    Google Scholar 

  16. Clinical and Laboratory Standards Institute. Evaluation of detection capability for clinical laboratory measurement procedures: approved guideline. CLSI document EP17-A2. 2nd ed. Wayne, PA: CLSI; 2012.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Catherine I. Dumur Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dumur, C.I. (2015). General Principles of Validating a Molecular Test. In: Idowu, M., Dumur, C., Garrett, C. (eds) Molecular Oncology Testing for Solid Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-16304-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16304-8_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16303-1

  • Online ISBN: 978-3-319-16304-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics